Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
MTLS 
Materialise NV (MTLS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: MTLS (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
2 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $9.07
1 Year Target Price $9.07
| 1 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -26.6% | Avg. Invested days 33 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/17/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 298.88M USD | Price to earnings Ratio 46 | 1Y Target Price 9.07 |
Price to earnings Ratio 46 | 1Y Target Price 9.07 | ||
Volume (30-day avg) 2 | Beta 1.25 | 52 Weeks Range 3.93 - 9.69 | Updated Date 09/17/2025 |
52 Weeks Range 3.93 - 9.69 | Updated Date 09/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.11 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 2.12% | Operating Margin (TTM) 4.21% |
Management Effectiveness
Return on Assets (TTM) 0.99% | Return on Equity (TTM) 2.28% |
Valuation
Trailing PE 46 | Forward PE - | Enterprise Value 224719494 | Price to Sales(TTM) 1.13 |
Enterprise Value 224719494 | Price to Sales(TTM) 1.13 | ||
Enterprise Value to Revenue 0.72 | Enterprise Value to EBITDA 5.95 | Shares Outstanding 59067200 | Shares Floating 24248185 |
Shares Outstanding 59067200 | Shares Floating 24248185 | ||
Percent Insiders 5.3 | Percent Institutions 14.51 |
Upturn AI SWOT
Materialise NV
Company Overview
History and Background
Materialise NV was founded in 1990 in Leuven, Belgium, by Wilfried Vancraen. It started as a rapid prototyping service bureau and has evolved into a global leader in 3D printing solutions and services.
Core Business Areas
- Materialise Medical: Provides software and services for surgical planning, patient-specific implants, and medical 3D printing.
- Materialise Manufacturing: Offers 3D printing services and software solutions for industrial manufacturing, including prototyping, tooling, and end-part production.
- Materialise Software: Develops and distributes a suite of software solutions for 3D printing, including data preparation, build processors, and 3D printing workflow management.
Leadership and Structure
Wilfried Vancraen is the founder and CEO. The company has a board of directors and operates with a functional organizational structure across its main business segments.
Top Products and Market Share
Key Offerings
- Mimics Innovation Suite: Software for medical image processing and 3D modeling. Market share is significant in personalized surgical planning. Competitors include 3D Systems, Stratasys, and Siemens Healthineers.
- Magics: Data preparation and build processor software for 3D printing. Widely used in various industries for optimizing 3D printing workflows. Competitors include Autodesk, ANSYS, and Netfabb.
- OnSite: Materialise's 3D printing on demand platform. It allows customers to easily order 3D printed parts online. Competitors include Protolabs, Xometry.
Market Dynamics
Industry Overview
The 3D printing industry is experiencing significant growth, driven by increasing adoption across healthcare, aerospace, automotive, and consumer goods. Key trends include advancements in materials, software, and printing technologies.
Positioning
Materialise NV is a leading player in the 3D printing market, particularly in software and medical applications. Its competitive advantages include its extensive software portfolio, strong industry expertise, and established partnerships.
Total Addressable Market (TAM)
The global 3D printing market is projected to reach hundreds of billions of USD in the next decade. Materialise is well-positioned to capture a significant share of this market through its diverse portfolio and strategic partnerships.
Upturn SWOT Analysis
Strengths
- Strong software portfolio
- Expertise in medical applications
- Established partnerships
- Global presence
- Extensive 3D printing services
Weaknesses
- Relatively small compared to larger competitors
- Reliance on specific industries
- Exposure to economic cycles
- Profitability can fluctuate
Opportunities
- Growing adoption of 3D printing in healthcare
- Expansion into new industries and applications
- Strategic acquisitions
- Development of new materials and technologies
- Increased government funding and support for 3D printing
Threats
- Competition from larger 3D printing companies
- Technological disruptions
- Economic downturns
- Intellectual property risks
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- DDD
- SSYS
- ONVO
Competitive Landscape
Materialise NV competes with larger 3D printing companies but differentiates itself through its software expertise and focus on medical applications. It holds a competitive advantage in specific niches but faces challenges in competing across the entire 3D printing market.
Major Acquisitions
Link3D
- Year: 2021
- Acquisition Price (USD millions): 33.5
- Strategic Rationale: The acquisition of Link3D was intended to strengthen Materialise's software platform for additive manufacturing operations management.
Growth Trajectory and Initiatives
Historical Growth: Materialise has experienced steady growth in revenue and market share over the past years, driven by increasing adoption of 3D printing and its strategic initiatives.
Future Projections: Analysts project continued growth for Materialise, driven by its strong position in the medical and industrial 3D printing markets. Specific projections vary depending on market conditions and company performance.
Recent Initiatives: Recent initiatives include strategic partnerships, acquisitions, and new product launches focused on expanding its market reach and technological capabilities.
Summary
Materialise NV is a prominent player in the 3D printing industry, particularly renowned for its software solutions and medical applications. It demonstrates strengths in partnerships and a global presence. However, it must monitor increasing competition and profitability. The company has significant growth potential with the expanding applications of 3D printing.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Industry Reports
- Analyst Reports
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered investment advice. Market share estimates are approximate. Financial performance data should be verified with official company filings.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Materialise NV
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2014-06-25 | CEO - | ||
Sector Technology | Industry Software - Application | Full time employees 488 | Website https://www.materialise.com |
Full time employees 488 | Website https://www.materialise.com | ||
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, website, and picture archiving and communication system. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.